OBJECTIVE: To assess the potential for recovery of impaired microvascular function in collateral dependent myocardium after recanalisation of a chronic total coronary occlusion and the determinants of this recovery. PATIENTS AND DESIGN: 120 patients underwent a successful recanalisation of a chronic total coronary occlusion (duration > 2 weeks) and a follow up angiography after a mean (SD) of 5.0 (1.2) months. The coronary flow velocity reserve (CFVR) and the fractional flow reserve were measured after recanalisation and at follow up. Global and regional left ventricular (LV) function were analysed by quantitative angiography. RESULTS: Microvascular dysfunction, defined by a CFVR < 2.0 and a fractional flow reserve > or = 0.75, was observed in 55 (46%) patients after recanalisation. Microvascular function improved during follow up in 24 (20%). The CFVR increased during follow up from 2.01 (0.58) to 2.50 (0.79) (p < 0.001), due to a decrease in basal average peak velocity from 30.7 (14.9) cm/s to 25.5 (13.3) cm/s (p = 0.001). Improved microvascular function was associated with an improved regional LV function, shown by a correlation between increased wall motion severity index and increased CFVR (r = 0.38, p = 0.003). The major determinant of microvascular dysfunction at baseline was the presence of diabetes mellitus (odds ratio 4.3, 95% confidence interval 1.8 to 10.2), which remained so at follow up (odds ratio 4.1, 95% confidence interval 1.3 to 13.4). Improvement of LV function was not impaired by the presence of microvascular dysfunction after recanalisation. CONCLUSIONS: The frequently observed microvascular dysfunction after recanalisation of a chronic total coronary occlusion is a transient phenomenon in most patients and is influenced by the presence of diabetes mellitus. It does not impede the recovery of LV function. Improved regional LV function is associated with improved microvascular function.
OBJECTIVE: To assess the potential for recovery of impaired microvascular function in collateral dependent myocardium after recanalisation of a chronic total coronary occlusion and the determinants of this recovery. PATIENTS AND DESIGN: 120 patients underwent a successful recanalisation of a chronic total coronary occlusion (duration > 2 weeks) and a follow up angiography after a mean (SD) of 5.0 (1.2) months. The coronary flow velocity reserve (CFVR) and the fractional flow reserve were measured after recanalisation and at follow up. Global and regional left ventricular (LV) function were analysed by quantitative angiography. RESULTS:Microvascular dysfunction, defined by a CFVR < 2.0 and a fractional flow reserve > or = 0.75, was observed in 55 (46%) patients after recanalisation. Microvascular function improved during follow up in 24 (20%). The CFVR increased during follow up from 2.01 (0.58) to 2.50 (0.79) (p < 0.001), due to a decrease in basal average peak velocity from 30.7 (14.9) cm/s to 25.5 (13.3) cm/s (p = 0.001). Improved microvascular function was associated with an improved regional LV function, shown by a correlation between increased wall motion severity index and increased CFVR (r = 0.38, p = 0.003). The major determinant of microvascular dysfunction at baseline was the presence of diabetes mellitus (odds ratio 4.3, 95% confidence interval 1.8 to 10.2), which remained so at follow up (odds ratio 4.1, 95% confidence interval 1.3 to 13.4). Improvement of LV function was not impaired by the presence of microvascular dysfunction after recanalisation. CONCLUSIONS: The frequently observed microvascular dysfunction after recanalisation of a chronic total coronary occlusion is a transient phenomenon in most patients and is influenced by the presence of diabetes mellitus. It does not impede the recovery of LV function. Improved regional LV function is associated with improved microvascular function.
Authors: J Herrmann; M Haude; A Lerman; R Schulz; L Volbracht; J Ge; A Schmermund; H Wieneke; C von Birgelen; H Eggebrecht; D Baumgart; G Heusch; R Erbel Journal: Circulation Date: 2001-05-15 Impact factor: 29.690
Authors: T Nishida; C Di Mario; M J Kern; T J Anderson; I Moussa; R Bonan; T Muramatsu; A C Jain; J Suarez de Lezo; S Y Cho; I T Meredith; J W Moses; A Colombo Journal: Eur Heart J Date: 2002-02 Impact factor: 29.983
Authors: J A Suero; S P Marso; P G Jones; S B Laster; K C Huber; L V Giorgi; W L Johnson; B D Rutherford Journal: J Am Coll Cardiol Date: 2001-08 Impact factor: 24.094
Authors: B De Bruyne; F Hersbach; N H Pijls; J Bartunek; J W Bech; G R Heyndrickx; K L Gould; W Wijns Journal: Circulation Date: 2001-11-13 Impact factor: 29.690
Authors: Gerald S Werner; Philipp Bahrmann; Oliver Mutschke; Ulf Emig; Stefan Betge; Markus Ferrari; Hans R Figulla Journal: J Am Coll Cardiol Date: 2003-07-16 Impact factor: 24.094
Authors: J P Melchior; P A Doriot; P Chatelain; B Meier; P Urban; L Finci; W Rutishauser Journal: J Am Coll Cardiol Date: 1987-04 Impact factor: 24.094
Authors: Kathleen Kearney; Ravi S Hira; Robert F Riley; Arun Kalyanasundaram; William L Lombardi Journal: Curr Atheroscler Rep Date: 2017-04 Impact factor: 5.113
Authors: Xin Long; Eric A Mokelke; Zachary P Neeb; Mouhamad Alloosh; Jason M Edwards; Michael Sturek Journal: J Pharmacol Exp Ther Date: 2010-09-20 Impact factor: 4.030
Authors: Daniëlle C J Keulards; Grigoris V Karamasis; Osama Alsanjari; Jesse P A Demandt; Marcel Van't Veer; Jo M Zelis; Simon A Dello; Mohamed El Farissi; Klio Konstantinou; Kare H Tang; Paul A Kelly; Thomas R Keeble; Nico H J Pijls; John R Davies; Koen Teeuwen Journal: J Am Heart Assoc Date: 2020-04-22 Impact factor: 5.501
Authors: David C Tong; Robert Whitbourn; Andrew MacIsaac; Andrew Wilson; Andrew Burns; Sonny Palmer; Jamie Layland Journal: Front Cardiovasc Med Date: 2018-01-12